ENGVALL et al. V. DAVID et al. - Page 16




                                      1.        Claim interpretation                                                                                                  
                             For the purpose of the description requirement  issue, Engvall’s claim 17 is representative.                                              
                   We have reproduced claim 17 below, adding indentation for clarity:                                                                                  
                                                 17.       In  an  immunometric  assay  to  determine  the  presence  or                                               
                                                 concentration  of  an  antigenic  substance  in  a  sample  of  a  fluid                                              
                                                 comprising                                                                                                            
                                                           forming a ternary complex of                                                                                
                                                                    a first labeled antibody,                                                                          
                                                                    said antigenic substance, and                                                                      
                                                                    a second antibody, said second antibody being bound                                                
                                                                    to a solid carrier insoluble in said fluid                                                         
                                                           wherein the presence of the antigenic substance in the samples                                              
                                                           is  determined by measuring either the amount of labeled                                                    
                                                           antibody bound to the solid carrier or the amount of unreacted                                              
                                                           labeled antibody,                                                                                           
                                                                    the improvement comprising employing monoclonal                                                    
                                                                    antibodies having an affinity for the antigenic                                                    
                                                                    substance of at least about 10  liters/mole for each of8                                                           
                                                                    said labeled antibody and said antibody bound to a                                                 
                                                                    solid carrier. [Emphasis added.]                                                                   
                   As we did with the count, we construe the phrase “at least about 10  liters/mole” as indicating  a8                                                         
                   lower limit for the range of the affinity necessary to use the claimed invention.   We interpret  “10 ”                      8                      
                   to mean 1 x 10 .  The phrase “at least” indicates the stated affinity constant is a minimum value.  The8                                                                                                                                 
                   word “about” adds some imprecision and extends the minimum affinity constant to a value somewhat                                                    
                                     8                                                              8                                                              
                   below 1 x 10 .  In other words, we interpret “at least about 10  liters/mole” to indicate a range                                                   
                                                                8                                                                                                      
                   beginning somewhat below  1 x 10  liters/mole and extending to 4.                                                                                   
                                                 a.        The materiality of the affinity limitation                                                                  
                             In opposing David’s motion, Engvall argued that the affinity limitation of claims 8 to 27 is not                                          
                   material.  Paper 39, pp. 3-8.  Implicitly, Engvall asserts that the purported lack of materiality excuses                                           
                   Engvall from the written description requirements of 35 U.S.C. § 112, ¶ 1.  The statute and  the case                                               
                   law interpreting the statute are clearly to the contrary.  The first paragraph of § 112 expressly requires                                          
                   that the “specification shall contain a written description of the invention....”   It is well settled that                                         
                   the “invention is, for the purpose of the 'written description' inquiry, whatever is now claimed.”   Vas-                                           



                                                                                 13                                                                                    





Page:  Previous  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  Next 

Last modified: November 3, 2007